we have studied the effects of transporter blockers on PPI in wild-type and DAT KO mice. Treatments with High dose psychostimulants that block DAT as well as the norepinephrine (NET) and serotonin ...

One such systemic treatment is metaiodobenzylguanidine (MIBG, iobenguane), which is a substrate for the norepinephrine reuptake transporter (NET) that is often overexpressed on the cell surface of ...

The prescribing information for Qelbree (viloxazine extended-release capsules) has been updated with new pharmacodynamic and lactation data.

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...

The results for the first time describe the tightly synchronized oscillations in the neurotransmitter norepinephrine (NE), cerebral blood, and cerebrospinal fluid (CSF) that combine during non ...

highlighting its partial agonist activity at the serotonin 5-HT2C receptor and inhibition of the norepinephrine transporter. These additions emphasize the multimodal pharmacodynamics of Qelbree in ...